![Sung-Yeon Im](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sung-Yeon Im
Direttore/Membro del Consiglio presso HANALL BIOPHARMA CO., LTD.
Profilo
Sung-Yeon Im is currently the Director & Managing Director at HANALL BIOPHARMA Co., Ltd., Director at Daewoong Development Co., Ltd., and Auditor at Daewoong Bio, Inc. and Daewoong Management Development Institute.
Previously, Mr. Im was an Executive Board Member & Head-Accounting at Daewoong Co., Ltd.
Mr. Im received an undergraduate degree from Hong-Ik University and a graduate degree from Korea Advanced Institute of Science & Technology.
Posizioni attive di Sung-Yeon Im
Società | Posizione | Inizio |
---|---|---|
HANALL BIOPHARMA CO., LTD. | Direttore/Membro del Consiglio | 22/03/2019 |
Daewoong Development Co., Ltd.
![]() Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Direttore/Membro del Consiglio | - |
Daewoong Bio, Inc.
![]() Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Comptroller/Controller/Auditor | - |
Daewoong Management Development Institute | Comptroller/Controller/Auditor | - |
Precedenti posizioni note di Sung-Yeon Im
Società | Posizione | Fine |
---|---|---|
DAEWOONG CO., LTD. | Comptroller/Controller/Auditor | - |
Formazione di Sung-Yeon Im
Hong-Ik University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
DAEWOONG CO., LTD. | Health Technology |
HANALL BIOPHARMA CO., LTD. | Health Technology |
Aziende private | 3 |
---|---|
Daewoong Development Co., Ltd.
![]() Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Finance |
Daewoong Bio, Inc.
![]() Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Commercial Services |
Daewoong Management Development Institute |
- Borsa valori
- Insiders
- Sung-Yeon Im